Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Routine Surveillance

PROVIDER: PRJNA1006559 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25684760_1.fastq.gz	Fastqsanger.gz
	SRR25684760_2.fastq.gz	Fastqsanger.gz
	SRR25825339_1.fastq.gz	Fastqsanger.gz
	SRR25825339_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Project description:Shigella isolates for routine surveillance

| PRJNA903515 | ENA

IMD surveillance Belgium

Project description:Strains from routine IMD surveillance Belgium

| PRJEB46584 | ENA

Strain from routine IMD surveillance in Belgium

Project description:Strain from routine IMD surveillance in Belgium

| PRJEB45732 | ENA

Routine Surveillance

Project description:Strain from routine IMD surveillance in Belgium

| PRJEB37139 | ENA

Project description:New York City Routine Pathogen Surveillance Sequencing Data

| PRJNA1020074 | ENA

Molecular surveillance of STEC

Project description:Routine surveillance of STEC at the Belgian NRC STEC

| PRJEB54005 | ENA

Project description:Whole genome sequencing of Neisseria meningitidis from routine surveillance

| PRJNA1127336 | ENA

Bacteria

Project description:Routine surveillance of E. coli and Shigella by Public Health England

| PRJNA315192 | ENA

A peripheral blood gene expression signature diagnoses subclinical acute rejection [discovery]

Project description:Histological features of acute rejection can be detected in surveillance biopsies despite stable graft function and can negatively impact graft outcomes. However, routine surveillance biopsies for detection of subclinical rejection are not generally performed due to potential risks and costs associated with repeated biopsies. Noninvasive biomarkers are required to facilitate early detection of acute rejection and borderline changes. We examined the impact of histological abnormalities at 3-month in surveillance biopsies on graft outcomes in kidney transplant recipients from the prospective Genomics of Chronic Allograft Rejection (GoCAR) study. We then performed RNA sequencing on whole blood collected at the time of biopsy in 88 patients (22 vs. 66) to identify transcripts associated with histological abnormalities. Subjects with subclinical ACR or borderline ACR at 3 month (ACR-3) had higher risk of subsequent clinical acute rejection at 12 and 24 month (P < 0.05), more rapid functional decline (P < 0.05) and a decreased graft survival in adjusted cox analysis (P < 0.01) than patients with no abnormalities on 3-month biopsy. We then identified a 17-gene signature in peripheral blood that accurately diagnosed ACR-3.

2019-09-11 | GSE120396 | GEO

human metagenome

Project description:Routine Autopsy for Population Health Surveillance Revealed Through Antibiotic Resistance Gene Detection

| PRJNA466231 | ENA